News

Safe Supply Streaming Portfolio Company, Safety Strips, Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - May 7, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply"…

5 months ago

NervGen Files Management Information Circular and Announces Board of Directors Transition

Bill Radvak to transition to Board Advisor following decision to not stand for re-election to NervGen's Board of DirectorsAnnual General…

5 months ago

FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia

TORONTO, ON / ACCESSWIRE / May 7, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

5 months ago

Avinger to Announce First Quarter 2024 Results on May 15, 2024

REDWOOD CITY, CA / ACCESSWIRE / May 7, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

5 months ago

Ainos Raises $9 Million in Growth Capital with Existing Shareholder

Proceeds for scaling up the company's VELDONA and AI Nose growth initiativesConvertible note convertible at $4.5 per share placed with…

5 months ago

CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors

Patricia Verduin, PhD, brings extensive science, technology, and sustainability expertise as well as business acumen to CMTA Board of DirectorsPatricia's…

5 months ago

Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting

    Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A. Formalities…

5 months ago

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa

Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER,…

5 months ago

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights

- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on…

5 months ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30…

5 months ago